H. Gardner
Molecular Biology · Journal of Pathology · 2003–2018
A researcher in the Science corpus: 3 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 43 citations into it
- Oncology — 14 citations into it
- Immunology — 12 citations into it
- Infectious Diseases — 12 citations into it
- Surgery — 9 citations into it
Whom H. Gardner trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from H. Gardner's perspective
Ordered by how strongly the researchers H. Gardner trusts endorse each paper. Same corpus, a different order for every researcher.
- A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses (Nature Medicine)
- Intestinal inflammation targets cancer-inducing activity of the microbiota (Science)
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota (Science)
- Cancer and the microbiota (Science)
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy (Science)
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth (Nature)
- Diversity of the Human Intestinal Microbial Flora (Science)
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. (Genome Research)
- The microbial metabolites, short chain fatty acids, regulate colonic Treg cell homeostasis (Science)
- Cancer immunotherapy comes of age (Nature)
Their papers
- Cyclin E ablation in the mouse. (2003) — 692 citations
- The microbiome and cancer (2018) — 757 citations
- Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. (2009) — 639 citations